Literature DB >> 9841872

Activation of phospholipase A2 in human neutrophils by polyunsaturated fatty acids and its role in stimulation of superoxide production.

B S Robinson1, C S Hii, A Ferrante.   

Abstract

Although polyunsaturated fatty acids (PUFA) have been shown to stimulate neutrophil responses such as the oxygen-dependent respiratory burst (superoxide production), the mechanisms involved still remain undefined. Here we investigate the effect of PUFA on the phospholipase A2 (PLA2)-signal transduction process in human neutrophils. Exogenous eicosatetraenoic acid [arachidonic acid; C20:4(n-6)] or docosahexaenoic acid [C22:6(n-3)] promoted the release of [3H]C20:4(n-6) from prelabelled neutrophils in a time- and dose-dependent manner, which is indicative of PLA2 activation. The release of [3H]C20:4(n-6) from the cells by C20:4(n-6) and C22:6(n-3) was suppressed by PLA2 inhibitors. Other PUFA ¿eicosapentaenoic [C20:5(n-3)], octadecatrienoic [gamma-linolenic; C18:3(n-6)] and octadecadienoic [linoleic; C18:2(n-6)] acids¿ also had the ability to release [3H]C20:4(n-6); however, certain C20:4(n-6) derivatives [15-hydroperoxyeicosatetraenoic acid, 15-hydroxyeicosatetraenoic acid and C20:4(n-6) methyl ester] and saturated fatty acids [octadecanoic (stearic; C18:0) and eicosanoic (arachidic; C20:0) acids] had no significant effect. Treatment of the neutrophils with exogenous C22:6(n-3) caused the mass of endogenous unesterified C20:4(n-6) to increase. Incubation of the leucocytes with C20:4(n-6) or C22:6(n-3) evoked activation of the 85 kDa cytosolic PLA2 (cPLA2) and the 14 kDa secretory PLA2 (sPLA2), but not the cytosolic Ca2+-independent PLA2. In contrast, C20:0 did not activate any of the PLA2 isoforms. Activation of cPLA2 by PUFA was found to precede that of sPLA2. C22:6(n-3), C20:4(n-6) and other PUFA induced punctate localization of cPLA2 in the cells, which was not observed with saturated fatty acids. Pretreatment of the leucocytes with PLA2 inhibitors markedly decreased superoxide production induced by C20:4(n-6). These results show that PUFA activate PLA2 in neutrophils, which might have a mandatory role in biological responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841872      PMCID: PMC1219911          DOI: 10.1042/bj3360611

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  Diversity of group types, regulation, and function of phospholipase A2.

Authors:  E A Dennis
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

2.  Activation of mitogen-activated protein kinase by arachidonic acid in rat liver epithelial WB cells by a protein kinase C-dependent mechanism.

Authors:  C S Hii; A Ferrante; Y S Edwards; Z H Huang; P J Hartfield; D A Rathjen; A Poulos; A W Murray
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

3.  Intense rises of unesterified arachidonate plasma levels in stressed humans.

Authors:  G Deby-Dupont; H Ducarne; C de Landsheere; J C Ancion; F X Noël; L Radoux; C Deby
Journal:  Biomed Pharmacother       Date:  1983       Impact factor: 6.529

4.  5-Lipoxygenase products modulate the activity of the 85-kDa phospholipase A2 in human neutrophils.

Authors:  J Wijkander; J T O'Flaherty; A B Nixon; R L Wykle
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

5.  Human neutrophils store type II 14-kDa phospholipase A2 in granules and secrete active enzyme in response to soluble stimuli.

Authors:  M D Rosenthal; M N Gordon; E S Buescher; J H Slusser; L K Harris; R C Franson
Journal:  Biochem Biophys Res Commun       Date:  1995-03-17       Impact factor: 3.575

6.  Effect of exogenous fatty acids with greater than 22 carbon atoms (very long chain fatty acids) on superoxide production by human neutrophils.

Authors:  S J Hardy; A Ferrante; A Poulos; B S Robinson; D W Johnson; A W Murray
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

Review 7.  Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C.

Authors:  W A Khan; G C Blobe; Y A Hannun
Journal:  Cell Signal       Date:  1995-03       Impact factor: 4.315

8.  Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages.

Authors:  J Balsinde; I D Bianco; E J Ackermann; K Conde-Frieboes; E A Dennis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  Polyenoic very-long-chain fatty acids mobilize intracellular calcium from a thapsigargin-insensitive pool in human neutrophils. The relationship between Ca2+ mobilization and superoxide production induced by long- and very-long-chain fatty acids.

Authors:  S J Hardy; B S Robinson; A Ferrante; C S Hii; D W Johnson; A Poulos; A W Murray
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

10.  Inhibitory effects of arachidonic acid (20:4,n-6) and its monohydroperoxy- and hydroxy-metabolites on procoagulant activity in endothelial cells.

Authors:  E J Bates; A Ferrante; A Poulos; L Smithers; D A Rathjen; B S Robinson
Journal:  Atherosclerosis       Date:  1995-07       Impact factor: 5.162

View more
  3 in total

1.  Regulation of CRIg expression and phagocytosis in human macrophages by arachidonate, dexamethasone, and cytokines.

Authors:  Nick N Gorgani; Umaporn Thathaisong; Violet R S Mukaro; Ornnuthchar Poungpair; Amanda Tirimacco; Charles S T Hii; Antonio Ferrante
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

2.  Effect of polyunsaturated fatty acids on the reactive oxygen and nitrogen species production by raw 264.7 macrophages.

Authors:  Gabriela Ambrozova; Michaela Pekarova; Antonin Lojek
Journal:  Eur J Nutr       Date:  2009-09-26       Impact factor: 5.614

3.  The effect of ω-fatty acids on the expression of phospholipase A2 group 2A in human gastric cancer patients.

Authors:  Mahboube Shariati; Mahmoud Aghaei; Ahmad Movahedian; Mohammad Hosein Somi; Homayun Dolatkhah; Ahmad Mirza Aghazade
Journal:  J Res Med Sci       Date:  2016-02-23       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.